Clinical Features of Neurodevelopmental Outcomes in Children with Preterm Severe Fetal Growth Restriction: A Retrospective Observational Study.
developmental quotient
fetal growth restriction
neurodevelopment
preterm birth
small for gestational age
Journal
JMA journal
ISSN: 2433-3298
Titre abrégé: JMA J
Pays: Japan
ID NLM: 101769797
Informations de publication
Date de publication:
15 Jul 2022
15 Jul 2022
Historique:
received:
24
02
2022
accepted:
26
04
2022
entrez:
22
8
2022
pubmed:
23
8
2022
medline:
23
8
2022
Statut:
ppublish
Résumé
Fetal growth restriction (FGR) is a clinical condition wherein a fetus fails to achieve the expected growth potential. Although FGR is the leading cause of perinatal morbidity and mortality, there is a lack of knowledge about the long-term developmental outcomes of children who had FGR in Japan. Here, we sought to clarify the features of neurodevelopmental outcomes in preterm-born children with severe FGR (sFGR) and identify associated clinical factors. The clinical data of 26 preterm sFGR cases and 26 preterm appropriate for gestational age (AGA) cases with a similar gestational age distribution were reviewed retrospectively. Developmental quotient (DQ) scores assessed during the 1- and 2-year corrected ages using the Kyoto Scale of Psychological Development were analyzed. sFGR was diagnosed at 26 (18-34) weeks of gestation, and the gestational age at delivery was 31 (25-36) weeks. The overall DQ scores of children in the sFGR group were significantly lower than those in the AGA group (80 vs. 90.5, Our results indicate that preterm-born children with sFGR have greater neurodevelopmental impairment than preterm-born children without FGR, specifically in terms of the DQ scores for the Language-Social area. It is imperative to encourage continuous long-term follow-up and appropriate interventions after birth.
Identifiants
pubmed: 35992293
doi: 10.31662/jmaj.2022-0047
pmc: PMC9358274
doi:
Types de publication
Journal Article
Langues
eng
Pagination
341-348Informations de copyright
Copyright © Japan Medical Association.
Déclaration de conflit d'intérêts
None
Références
JAMA Pediatr. 2020 Aug 1;174(8):772-781
pubmed: 32453414
Obstet Gynecol. 2002 Mar;99(3):490-6
pubmed: 11864679
Clin Exp Pediatr. 2021 Jul;64(7):313-321
pubmed: 33171036
Psychiatry Clin Neurosci. 2009 Apr;63(2):241-3
pubmed: 19335396
Brain Dev. 2016 Feb;38(2):188-95
pubmed: 26265090
Obstet Gynecol. 2021 Feb 1;137(2):e16-e28
pubmed: 33481528
Am J Obstet Gynecol. 2018 Feb;218(2S):S745-S761
pubmed: 29422210
Pediatr Int. 2008 Feb;50(1):23-8
pubmed: 18279200
BJOG. 2018 Jan;125(1):16-25
pubmed: 29024294
Am J Obstet Gynecol. 2011 Jan;204(1):34.e1-9
pubmed: 21056403
Am J Obstet Gynecol. 2009 Apr;200(4):409.e1-6
pubmed: 19217594
Indian Pediatr. 2020 Apr 15;57(4):296-300
pubmed: 32038037
BJOG. 2015 Jul;122(8):1062-72
pubmed: 25990812
Brain Dev. 2016 Apr;38(4):377-85
pubmed: 26542468
Am J Obstet Gynecol. 2011 Apr;204(4):288-300
pubmed: 21215383